BESUNYEN Posts 21.48% Net Profit Growth in Interim Results
Stock News
Aug 07
BESUNYEN (00926) has announced its interim results for the six months ended June 30, 2026, reporting a net profit of RMB 15.066 million, a 21.48% increase year-on-year.
The company achieved revenue of RMB 305 million, up 17.74% compared to the same period last year, with basic earnings per share standing at RMB 0.12.
The revenue growth was primarily driven by a sharp 43.8% increase in sales from its four-tea product line, though this was partially offset by a decline in sales volumes of other pharmaceutical products and health supplements, the company stated in its filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.